In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, ...
Darlene Soave Joins Cell Source's Board of Directors PR Newswire NEW YORK , April 1, 2021 /PRNewswire/ -- Cell Source, Inc. (OTC: CLCS) ( " Cell Source" or "the Company"), is the world leader in Veto Cell based innovative immunotherapy and today announced tha...
USPTO Issues New Patents for Cell Source's Veto Cell Technology Patents Validate Veto Cells as a Critical Enabler for Cell Therapies Such as CAR-T, TCR, and NK as well as a Powerful, Stand-alone Immunotherapy in the Treatment of Cancer, Viral and Bacterial Infections PR News...
Veto T-Cell Bone Marrow Transplant Safely Demonstrates Potential Cure for Sickle Cell Anemia in Preclinical Trials Well-established Mouse Model Utilizes T-cell-depleted, Mismatched Donor Bone Marrow Transplants in Conjunction with Veto T-cell Transplants to Correct Sickle Cell D...
Pediatric Stem Cell Transplantation Expert and Industry Leader Dr. Joseph Rosenthal Joins Cell Source's Scientific Advisory Board Director of Pediatric Hematology-Oncology and Barron Hilton Professor & Chair in Pediatrics at City of Hope National Medical Center Brings Decade...
News, Short Squeeze, Breakout and More Instantly...
In recent years, biomedical research on topics surrounding longevity and aging has gained a tremendous amount of traction. The biotech industry as well as major pharmaceutical companies, have also jumped onto the bandwagon of discovering ways to alter and reverse the aging process. Currently, ...
Darlene Soave Joins Cell Source's Board of Directors PR Newswire NEW YORK , April 1, 2021 /PRNewswire/ -- Cell Source, Inc. (OTC: CLCS) ( " Cell Source" or "the Company"), is the world leader in Veto Cell based innovative immunotherapy and today announced tha...
USPTO Issues New Patents for Cell Source's Veto Cell Technology Patents Validate Veto Cells as a Critical Enabler for Cell Therapies Such as CAR-T, TCR, and NK as well as a Powerful, Stand-alone Immunotherapy in the Treatment of Cancer, Viral and Bacterial Infections PR News...